EnerSpar Corp. (TSE:NRX) has released an update.
NurExone Biologic Inc. shareholders showed strong support for company proposals during the 2024 Annual Meeting, with over 99% approval for all resolutions including director elections, auditor reappointment, and amendments to the equity incentive plan. Additionally, the company announced significant grants of stock options and restricted share units to various team members under the Equity Incentive Plan.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
